We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNRO icon
126
Monro
MNRO
$525M
$16.8M 0.25%
295,503
-7,743
-3% -$403K
NDSN icon
127
Nordson
NDSN
$16.5B
$16.7M 0.24%
114,107
+79
+0.1% +$10.2K
HAE icon
128
Haemonetics
HAE
$3.58B
$16.7M 0.24%
287,036
-7,755
-3% -$408K
AWR icon
129
American States Water
AWR
$3.39B
$16.4M 0.24%
283,860
-6,174
-2% -$338K
CHTR icon
130
Charter Communications
CHTR
$14.7B
$16.2M 0.24%
48,308
-1,322
-3% -$449K
TR icon
131
Tootsie Roll Industries
TR
$2.82B
$16M 0.24%
575,063
+6,726
+1% +$188K
IPGP icon
132
IPG Photonics
IPGP
$3.89B
$15.4M 0.23%
71,728
-17,078
-19% -$3.62M
GMED icon
133
Globus Medical
GMED
$10.4B
$15M 0.22%
365,613
-9,728
-3% -$341K
EXLS icon
134
EXL Service
EXLS
$4.23B
$14.8M 0.22%
1,226,075
-30,075
-2% -$367K
HE icon
135
Hawaiian Electric Industries
HE
$2.33B
$14.5M 0.21%
402,331
-8,611
-2% -$312K
EAT icon
136
Brinker International
EAT
$8.02B
$14.5M 0.21%
372,431
-21,223
-5% -$732K
MKC icon
137
McCormick & Company Non-Voting
MKC
$13.4B
$14.4M 0.21%
283,254
+4,960
+2% +$247K
FFIV icon
138
F5
FFIV
$22.1B
$14.4M 0.21%
109,843
+23,359
+27% +$2.9M
ALV icon
139
Autoliv
ALV
$8.6B
$14.4M 0.21%
157,423
-1,589
-1% -$144K
IPCC
140
DELISTED
Infinity Property & Casualty C
IPCC
$14.3M 0.21%
134,810
-3,042
-2% -$309K
WEX icon
141
WEX
WEX
$6.11B
$14.3M 0.21%
100,920
-2,385
-2% -$298K
CTSH icon
142
Cognizant
CTSH
$21.5B
$14.2M 0.21%
200,092
+3,035
+2% +$222K
FDS icon
143
Factset
FDS
$9.05B
$14M 0.21%
72,717
+713
+1% +$137K
IFF icon
144
International Flavors & Fragrances
IFF
$19.4B
$13.9M 0.2%
91,144
-690
-0.8% -$104K
AZO icon
145
AutoZone
AZO
$48.3B
$13.9M 0.2%
19,548
-460
-2% -$294K
WAFD icon
146
WaFd
WAFD
$2.72B
$13.9M 0.2%
404,570
-9,868
-2% -$339K
HSIC icon
147
Henry Schein
HSIC
$9.74B
$13.8M 0.2%
251,007
+247,373
+6,807% +$14.3M
ANIK icon
148
Anika Therapeutics
ANIK
$199M
$13.5M 0.2%
250,148
-7,130
-3% -$395K
MTX icon
149
Minerals Technologies
MTX
$2.31B
$13.4M 0.2%
195,162
-5,330
-3% -$379K
CRL icon
150
Charles River Laboratories
CRL
$10.9B
$13.4M 0.2%
+122,536
New +$13.3M
4 5
6
7 8

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.